Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTPγS binding

被引:25
作者
Geurts, M [1 ]
Hermans, E [1 ]
Maloteaux, JM [1 ]
机构
[1] Univ Catholique Louvain, Pharmacol Lab, FARL 5410, B-1200 Brussels, Belgium
关键词
S-35]GTP gamma S binding; spiperone; striatal membranes; G protein; D1 dopamine receptor; D2 dopamine receptor;
D O I
10.1016/S0024-3205(99)00412-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The dopamine receptor-mediated modulation of guanosine 5'-O-(gamma[S-35]thio)triphosphate ([S-35]GTP gamma S) binding has been characterized in rat striatal membranes. In optimized experimental conditions, the potency of dopamine was 4.47 mu M [3.02 - 6.61 mu M] and a maximal response representing 54.8 +/- 4.5 % increase above basal level was observed. Data obtained with different agonists and antagonists clearly revealed that the most important fraction of this response was reflecting D2 receptor activation. Further analysis with specific antagonists also supported evidence for the involvement of Dl dopamine receptors. The potencies of compounds interacting with D1 and D2 receptors were deduced from [S-35]GTP gamma S binding experiments and compared with their binding affinities for these receptors measured in similar experimental conditions. A good correlation between these parameters was observed, supporting the applicability of this technique for the study of dopamine receptors in the central nervous system.
引用
收藏
页码:1633 / 1645
页数:13
相关论文
共 50 条
[1]   Relationship between binding affinity and functional activity of nociceptin/orphanin FQ [J].
Adapa, ID ;
Toll, L .
NEUROPEPTIDES, 1997, 31 (05) :403-408
[2]   Pharmacological characterization of type 1 alpha metabotropic glutamate receptor-stimulated [S-35]-GTP gamma S binding [J].
Akam, EC ;
Carruthers, AM ;
Nahorski, SR ;
Challiss, RAJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (06) :1203-1209
[3]   DOPAMINE RECEPTOR AGONISTS - SELECTIVITY AND DOPAMINE-D1 RECEPTOR EFFICACY [J].
ANDERSEN, PH ;
JANSEN, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :335-347
[4]   PARTIAL AND FULL DOPAMINE D1-RECEPTOR AGONISTS IN MICE AND RATS - RELATION BETWEEN BEHAVIORAL-EFFECTS AND STIMULATION OF ADENYLATE-CYCLASE ACTIVITY INVITRO [J].
ARNT, J ;
HYTTEL, J ;
SANCHEZ, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :259-267
[5]   DESIGN, SYNTHESIS, X-RAY-ANALYSIS, AND DOPAMINE RECEPTOR-MODULATING ACTIVITY OF MIMICS OF THE C5 HYDROGEN-BONDED CONFORMATION IN THE PEPTIDOMIMETIC 2-OXO-3(R)-[(2(S)-PYRROLIDINYLCARBONYL)AMINO]-1-PYRROLIDINEACETAMIDE [J].
BAURES, PW ;
OJALA, WH ;
GLEASON, WB ;
MISHRA, RK ;
JOHNSON, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (22) :3677-3683
[6]   SELECTIVITY OF SOME ERGOT DERIVATIVES FOR 5-HT1 AND 5-HT2 RECEPTORS OF RAT CEREBRAL-CORTEX [J].
BEART, PM ;
MCDONALD, D ;
CINCOTTA, M ;
DEVRIES, DJ ;
GUNDLACH, AL .
GENERAL PHARMACOLOGY, 1986, 17 (01) :57-62
[7]   INTERACTION OF DOPAMINE RECEPTOR LIGANDS WITH SUBTYPES OF THE OPIATE RECEPTOR [J].
BOUBLIK, JH ;
FUNDER, JW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 107 (01) :11-16
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
CHABERT C, 1994, J NEUROCHEM, V63, P62
[10]  
CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281